Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M103Revenue (TTM) $M4.7Net Margin (%)-670.7Altman Z-Score-15.1
Enterprise Value $M81.9EPS (TTM) $-2.2Operating Margin %-646.4Piotroski F-Score1
P/E(ttm)--Beneish M-Score-0.8Pre-tax Margin (%)-670.7Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %--Quick Ratio6.8Cash flow > EarningsN
Price/Sales21.55-y EBITDA Growth Rate %--Current Ratio6.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-80.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-128.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARDM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARDMJohn Paulson 2016-06-30 Add$4.18 - $5.13
($4.53)
$ 6.8852%Add 235.18%65,903
ARDMJohn Paulson 2016-03-31 Buy $2.65 - $4.44
($3.45)
$ 6.8899%New holding19,662
ARDMFirst Eagle Investment 2014-06-30 Buy 0.08%$0.185 - $9.52
($3.37)
$ 6.88104%New holding3,854,730
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARDM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ARDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Froehlich Juergen KurtChief Medical Officer 2016-06-21Sell333$4.4554.61view
THOMPSON VIRGILDirector 2013-12-13Sell84$6.81.18view
Grifols SADirector, 10% Owner 2013-08-27Sell0$01.18view
Boxer Capital, LLC10% Owner 2013-05-20Sell0$01.18view
DEF Associates Ltd.See footnote below 2012-01-01Sell0$01.18view
DEF Associates LPSee Footnote 1 below 2010-12-31Sell0$01.18view
First Eagle Value in BiotechnoSee remarks. 2009-02-23Sell0$01.18view
First Eagle Value in Biotechno10% Owner 2009-02-23Sell0$01.18view
Grimes D JefferyVP Legal Affairs, Secretary 2008-07-01Sell0$01.18view
RA Capital Biotech Fund II, L.10% Owner 2007-03-01Sell0$01.18view

Quarterly/Annual Reports about ARDM:

News about ARDM:

Articles On GuruFocus.com
First Eagle Adds to Stake in Aradigm Apr 28 2016 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 
Eveillard’s First Eagle Seizes 45% of Pharamaceutical Company, Aradigm Dec 19 2012 

More From Other Websites
3 Reasons Why Aradigm Corporation (ARDM) is a Great Momentum Stock Sep 22 2016
Aradigm Announces Last Patient Dosing Visit in ORBIT-3 and ORBIT-4 Phase 3 Studies of Pulmaquin in... Sep 22 2016
Aradigm Announces Last Patient Dosing Visit in ORBIT-3 and ORBIT-4 Phase 3 Studies of Pulmaquin in... Sep 22 2016
Aradigm to Host Analyst Meeting and Webcast on September 26 in New York City Sep 21 2016
Aradigm to Host Analyst Meeting and Webcast on September 26 in New York City Sep 21 2016
Aradigm (ARDM) Shares March Higher, Can It Continue? Sep 21 2016
Aradigm to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27 Sep 20 2016
ARADIGM CORP Financials Aug 18 2016
Aradigm Corp. :ARDM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
ARADIGM CORP Files SEC form 10-Q, Quarterly Report Aug 11 2016
ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 10 2016
Aradigm Announces Second Quarter 2016 Financial Results Aug 10 2016
Aradigm reports 2Q loss Aug 10 2016
Aradigm reports 2Q loss Aug 10 2016
Aradigm Announces Second Quarter 2016 Financial Results Aug 10 2016
ARADIGM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 10 2016
Aradigm Corp. :ARDM-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
Two Presentations on Aradigm's Inhaled Liposomal Ciprofloxacin Programs at the American Thoracic... May 11 2016
Two Presentations on Aradigm’s Inhaled Liposomal Ciprofloxacin Programs at the American Thoracic... May 11 2016
ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)